http://www.barchart.com/opinions/stocks/CYTK
Recent CYTK News
- Form 8-K - Current report • Edgar (US Regulatory) • 11/19/2024 11:02:49 AM
- Cytokinetics and Bayer Announce Exclusive Licensing Collaboration for Aficamten in Japan • GlobeNewswire Inc. • 11/19/2024 07:30:00 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/18/2024 09:31:26 PM
- Cytokinetics Presents New Data Relating to Aficamten and Hypertrophic Cardiomyopathy at the American Heart Association Scientific Sessions 2024 • GlobeNewswire Inc. • 11/16/2024 02:00:00 PM
- Cytokinetics Presents Additional Data From GALACTIC-HF at the American Heart Association Scientific Sessions 2024 • GlobeNewswire Inc. • 11/16/2024 02:00:00 PM
- Form SC 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 11/14/2024 06:28:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/13/2024 10:04:06 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/12/2024 09:08:21 PM
- Cytokinetics to Participate in the 2024 Jefferies London Healthcare Conference • GlobeNewswire Inc. • 11/12/2024 09:00:00 PM
- Cytokinetics Announces Initiation of Phase 1 Clinical Study of CK-4015089 • GlobeNewswire Inc. • 11/11/2024 12:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/07/2024 09:05:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/07/2024 09:05:15 PM
- Cytokinetics Reports Third Quarter 2024 Financial Results • GlobeNewswire Inc. • 11/06/2024 09:00:00 PM
- Cytokinetics Announces Six Upcoming Presentations at the American Heart Association Scientific Sessions 2024 • GlobeNewswire Inc. • 11/05/2024 09:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/04/2024 10:45:10 PM
- Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 11/04/2024 09:00:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/01/2024 08:43:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/31/2024 08:49:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/31/2024 08:45:30 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 10/29/2024 08:08:43 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 10/28/2024 08:12:34 PM
- Cytokinetics to Announce Third Quarter Results on November 6, 2024 • GlobeNewswire Inc. • 10/23/2024 08:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/16/2024 10:45:28 PM
FEATURED Key Metals Surge, Unlocking New Opportunities for Savvy Mining Investors • Nov 19, 2024 8:45 AM
FEATURED Greenlane Signs New U.S. Distribution Agreement with Veriteque USA, Manufacturer of the SwabTek™ and Verifique™ Brand of Field Test Kits • Nov 19, 2024 8:34 AM
Geo-Political Tensions and Trump's Increasing Military Budgets Could Boost Demand for Actelis' Cyber Hardened Networking Tech ($ASNS) • ASNS • Nov 19, 2024 10:24 AM
CBD Life Sciences Inc. (CBDL) Closes on LOI for Potential $8 Million Revenue Cannabis Dispensary • CBDL • Nov 19, 2024 8:00 AM
Are we about to see a comeback? Steakholder Foods Charges Forward with New Commitments from Multiple International Players as it Transitions to Revenue Generation • STKH • Nov 18, 2024 11:56 AM
North Bay Resources Announces Production of Gold Concentrate and Refinery Shipment at Bishop Gold Mill, California • NBRI • Nov 18, 2024 9:00 AM